Study identity card

Zuiani

United Kingdom United States of America
Share
  • Disease: Monkeypox virus infection
  • Study type: Randomised Clinical Trial
  • Study type descriptors: Interventional
  • Study aim: To assess the reactogenicity, safety, tolerability and immunogenicity of the multivalent vaccine candidate BNT166a in healthy participants with and without prior history of smallpox vaccination
  • Number of participants enrolled: Enrollment ongoing
  • Study enrolling from to

Study Data

  • Adults
  • General population
  • Monkeypox virus
  • Monkeypox virus infection
  • Vaccination
  • Pharmacological intervention
  • BNT166a

Other information

Funders:

  • BioNTech SE

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to